GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $921,000 | -0.5% | 17,500 | 0.0% | 0.05% | -6.9% |
| Q1 2019 | $926,000 | +0.2% | 17,500 | -22.2% | 0.06% | -18.3% |
| Q4 2018 | $924,000 | +62.1% | 22,500 | +50.0% | 0.07% | +129.0% |
| Q3 2018 | $570,000 | -15.9% | 15,000 | 0.0% | 0.03% | -18.4% |
| Q2 2018 | $678,000 | -12.3% | 15,000 | -6.2% | 0.04% | -5.0% |
| Q1 2018 | $773,000 | +44.5% | 16,000 | +17.6% | 0.04% | +60.0% |
| Q4 2017 | $535,000 | -60.7% | 13,600 | -83.5% | 0.02% | -55.4% |
| Q2 2016 | $1,363,000 | – | 82,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |